Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$425M |
| 2 |
Texas Instruments
TXN
|
+$403M |
| 3 |
AbbVie
ABBV
|
+$296M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$251M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$948M |
| 2 |
Gilead Sciences
GILD
|
+$701M |
| 3 |
SLB Ltd
SLB
|
+$520M |
| 4 |
Qualcomm
QCOM
|
+$273M |
| 5 |
AT&T
T
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 15.29% |
| 3 | Financials | 12.28% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TUP
2701
DELISTED
Tupperware Brands Corporation
TUP
| $1.42M | ﹤0.01% |
877,909
+1,868
| +0.2% | +$9.51K |
|
2702
Castle Biosciences
CSTL
$917M
| $1.42M | ﹤0.01% |
47,569
+21,383
| +82% | +$645K |
|
|
TBIO
2703
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.42M | ﹤0.01% |
142,108
+14,333
| +11% | +$117K |
|
2704
LCNB Corp
LCNB
$284M
| $1.42M | ﹤0.01% |
112,350
-3,587
| -3% | -$59K |
|
|
SLCT
2705
DELISTED
Select Bancorp, Inc.
SLCT
| $1.42M | ﹤0.01% |
185,491
| – | – |
|
2706
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $1.41M | ﹤0.01% |
9,409
-3,204
| -25% | -$595K |
|
2707
Brookfield Infrastructure Partners
BIP
$18.2B
| $1.41M | ﹤0.01% |
58,901
-8,057
| -12% | -$235K |
|
2708
CEL-SCI Corp
CVM
$26.9M
| $1.41M | ﹤0.01% |
4,062
+830
| +26% | +$303K |
|
2709
Metallus
MTUS
$899M
| $1.41M | ﹤0.01% |
434,752
-7,662
| -2% | -$42.9K |
|
|
TLRD
2710
DELISTED
Tailored Brands, Inc.
TLRD
| $1.4M | ﹤0.01% |
803,200
-53,155
| -6% | -$179K |
|
|
COWN
2711
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.4M | ﹤0.01% |
144,463
-5,987
| -4% | -$85.5K |
|
2712
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$118M
| $1.39M | ﹤0.01% |
54,887
-3,567
| -6% | -$92.9K |
|
2713
Standard BioTools
LAB
$286M
| $1.39M | ﹤0.01% |
548,478
+26,651
| +5% | +$87.6K |
|
2714
Western New England Bancorp
WNEB
$282M
| $1.39M | ﹤0.01% |
205,831
-4,526
| -2% | -$38.5K |
|
2715
Bloom Energy
BE
$68.6B
| $1.39M | ﹤0.01% |
266,194
+1,563
| +0.6% | +$13.3K |
|
2716
WisdomTree True Developed International Fund
DOL
$848M
| $1.39M | ﹤0.01% |
+37,618
| New | +$1.67M |
|
2717
KALA BIO
KALA
$17.8M
| $1.39M | ﹤0.01% |
63
+28
| +80% | +$447K |
|
2718
Q32 Bio
QTTB
$450M
| $1.38M | ﹤0.01% |
4,943
-238
| -5% | -$72.9K |
|
2719
Ardelyx
ARDX
$1.05B
| $1.38M | ﹤0.01% |
242,679
+57,723
| +31% | +$392K |
|
2720
WisdomTree Europe SmallCap Dividend Fund
DFE
$171M
| $1.38M | ﹤0.01% |
33,919
+30,119
| +793% | +$1.7M |
|
2721
RPC Inc
RES
$1.42B
| $1.38M | ﹤0.01% |
669,115
-61,571
| -8% | -$228K |
|
2722
Tucows
TCX
$128M
| $1.38M | ﹤0.01% |
28,561
-87
| -0.3% | -$4.87K |
|
|
CWBC
2723
Community West Bancshares
CWBC
$708M
| $1.38M | ﹤0.01% |
105,679
-4,227
| -4% | -$75.3K |
|
2724
ProShares UltraShort S&P500
SDS
$366M
| $1.37M | ﹤0.01% |
1,794
+355
| +25% | +$241K |
|
2725
W&T Offshore
WTI
$555M
| $1.37M | ﹤0.01% |
803,645
-42,241
| -5% | -$144K |
|
Similar funds
Bank of New York Mellon's Q1 2020 Portfolio in Review
As of Q1 2020, Bank of New York Mellon held 4,289 positions worth $302B, down 22% from $388B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q1 2020 filing shows 113 new, 1,571 increased, 2,175 reduced and 192 closed positions. Its largest new stake was 1Life Healthcare: 2,014,468 shares worth $36.6M. The largest sale was Starbucks, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2020 buy was 1Life Healthcare: 2,014,468 shares worth $36.6M.
- Bank of New York Mellon added most to Illumina in Q1 2020, an estimated $425M increase.
- Bank of New York Mellon's biggest Q1 2020 reduction was Starbucks, cutting an estimated $948M.
- Bank of New York Mellon fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $170M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $302B portfolio in Q1 2020.
- Bank of New York Mellon opened 113 new positions and closed 192 in Q1 2020.
- Bank of New York Mellon's portfolio value fell 22% quarter-over-quarter to $302B.
Based on Bank of New York Mellon's 13F filing for Q1 2020, filed 6 May 2020.